Jurgen Becker, Seyed Hamidreza Mahmoudpour, Dirk Schadendorf, Ulrike M. Leiter, Friedegund Elke Meier, Rudolf Alexander Herbst, Stephan Grabbe, Christoffer Gebhardt, Fabian Ziller, Claudia Pföhler, Peter Mohr, Lisa Zimmer, Emmanuelle Boutmy, Dina Oksen, Mairead Kearney, Katia Ruth, Sebastian Hoff, Margarita Shlaen, Selma Ugurel. "Real-world safety and effectiveness of avelumab in immune-compromised (IC) and non-IC patients with Merkel cell carcinoma (MCC): Results from a prospective German registry (MCC-TRIM).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.9543